top of page
Search
New NIHR Nottingham BRC Funded Research; Understanding novel Point of Care testing of Alkyl Quinolones for Pseudomonas Aeruginosa (UnPAQ) – a feasibility study
New NIHR Nottingham BRC Funded Research; Understanding novel Point of Care testing of Alkyl Quinolones for Pseudomonas Aeruginosa (UnPAQ)
Glenn Hearson
Apr 4
21
Investigating The Effects of Yoga Practice on Adults with Cystic Fibrosis
Investigating The Effects of Yoga Practice on Adults with Cystic Fibrosis
-
Jul 24, 2024
39
Artificial intelligence to Control acute pulmonary Exacerbations in Cystic Fibrosis
Artificial intelligence to Control acute pulmonary Exacerbations in Cystic Fibrosis
-
Jul 24, 2024
26
Impact of ELX/TEZ/IVA on Patients With Cystic Fibrosis (TRAJECTORY)
We have recently commenced a new study in conjunction with with Vertex Pharmaceuticals Incorporated and Cardiff and Vale University...
-
Aug 15, 2022
48
Experts from the University of Nottingham to develop new treatments for cystic fibrosis infections
Experts from the University of Nottingham have joined a Strategic Research Centre as part of a new international collaboration led by...
-
Oct 29, 2021
72
CF STORM a ground-breaking trial to assess management of CF patients daily healthcare routines
Dr Helen Barr of the NIHR Nottingham Biomedical Research Centre , will shortly commence recruitment into the CF STORM study at NUH...
-
Aug 11, 2021
81
sTREM-1 is elevated in cystic fibrosis and correlates with proteases
sTREM-1 (soluble triggering receptor expressed on myeloid cells-1) is a novel inflammatory marker that may be of clinical use in cystic fibr
-
Jan 19, 2017
47
Epigenetic dysregulation of interleukin 8 (CXCL8) hypersecretion in cystic fibrosis airway epithelia
Airway epithelial cells in cystic fibrosis (CF) overexpress Interleukin 8 (CXCL8) through poorly defined mechanisms. CXCL8 transcription is
-
Sep 11, 2016
17
bottom of page